Thomas F. Newton

6.1k total citations
123 papers, 4.7k citations indexed

About

Thomas F. Newton is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, Thomas F. Newton has authored 123 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Cellular and Molecular Neuroscience, 33 papers in Pharmacology and 30 papers in Cognitive Neuroscience. Recurrent topics in Thomas F. Newton's work include Neurotransmitter Receptor Influence on Behavior (66 papers), Substance Abuse Treatment and Outcomes (23 papers) and Cannabis and Cannabinoid Research (21 papers). Thomas F. Newton is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (66 papers), Substance Abuse Treatment and Outcomes (23 papers) and Cannabis and Cannabinoid Research (21 papers). Thomas F. Newton collaborates with scholars based in United States, Tunisia and United Kingdom. Thomas F. Newton's co-authors include Richard De La Garza, Ari D. Kalechstein, James J. Mahoney, Andrew F. Leuchter, Ian A. Cook, Walter Ling, Colin N. Haile, Michael Green, Donald O. Walter and Jennifer J. Dunkin and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and NeuroImage.

In The Last Decade

Thomas F. Newton

122 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas F. Newton United States	39	2.1k	1.4k	973	929	662	123	4.7k
Mark S. Gold United States	45	2.1k 1.0×	899 0.6×	1.2k 1.2×	1.3k 1.4×	920 1.4×	230	6.4k
Richard De La Garza United States	39	2.0k 0.9×	677 0.5×	807 0.8×	575 0.6×	423 0.6×	143	4.1k
Charles A. Dackis United States	39	2.8k 1.3×	889 0.6×	950 1.0×	1.0k 1.1×	1.2k 1.8×	82	5.1k
Boris B. Quednow Switzerland	41	2.2k 1.0×	1.5k 1.1×	748 0.8×	1.0k 1.1×	428 0.6×	216	5.7k
Suzette M. Evans United States	40	2.2k 1.0×	844 0.6×	1.3k 1.3×	1.2k 1.3×	609 0.9×	118	5.1k
Craig R. Rush United States	40	3.3k 1.6×	1.9k 1.3×	1.2k 1.2×	1.5k 1.6×	765 1.2×	193	5.6k
Carl L. Hart United States	45	2.2k 1.0×	1.3k 0.9×	2.2k 2.3×	581 0.6×	929 1.4×	100	5.4k
Anne Lingford‐Hughes United Kingdom	45	2.9k 1.3×	1.6k 1.1×	2.0k 2.1×	1.4k 1.6×	1.2k 1.8×	184	7.4k
William W. Stoops United States	35	1.9k 0.9×	702 0.5×	729 0.7×	726 0.8×	935 1.4×	168	3.8k
Stephen J. Heishman United States	46	1.9k 0.9×	1.1k 0.8×	2.1k 2.2×	539 0.6×	793 1.2×	120	6.2k

Countries citing papers authored by Thomas F. Newton

Since Specialization

Citations

This map shows the geographic impact of Thomas F. Newton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F. Newton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F. Newton more than expected).

Fields of papers citing papers by Thomas F. Newton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas F. Newton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F. Newton. The network helps show where Thomas F. Newton may publish in the future.

Co-authorship network of co-authors of Thomas F. Newton

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas F. Newton. A scholar is included among the top collaborators of Thomas F. Newton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas F. Newton. Thomas F. Newton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nielsen, David A., et al.. (2018). FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration. American Journal on Addictions. 27(7). 567–573. 11 indexed citations

Verrico, Christopher D., Colin N. Haile, James J. Mahoney, et al.. (2014). Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: A randomized, double blind, placebo-controlled human laboratory study. Drug and Alcohol Dependence. 141. 72–78. 34 indexed citations

Grasing, Kenneth, Deepan Mathur, Thomas F. Newton, & Cherilyn DeSouza. (2013). Individual predictors of the subjective effects of intravenous cocaine. Psychiatry Research. 208(3). 245–251. 5 indexed citations

Haile, Colin N., Richard De La Garza, James J. Mahoney, & Thomas F. Newton. (2013). Effects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase. Drug and Alcohol Dependence. 133(2). 759–762. 6 indexed citations

Mahoney, James J., et al.. (2012). The relationship between lifetime stress and addiction severity in cocaine-dependent participants. European Neuropsychopharmacology. 23(5). 351–357. 11 indexed citations

Haile, Colin N., Richard De La Garza, James J. Mahoney, et al.. (2012). The Impact of Disulfiram Treatment on the Reinforcing Effects of Cocaine: A Randomized Clinical Trial. PLoS ONE. 7(11). e47702–e47702. 18 indexed citations

Newton, Thomas F.. (2011). A Perhaps Unexpected Role of Norepinephrine in Actions of MDMA. Clinical Pharmacology & Therapeutics. 90(2). 215–216. 9 indexed citations

Sevak, Rajkumar J., Todd Zorick, Karen Miotto, et al.. (2010). Pilot Safety Evaluation of Varenicline for the Treatment of Methamphetamine Dependence. The FASEB Journal. 24(S1). 2 indexed citations

Mahoney, James J., et al.. (2010). Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants. Gender Medicine. 7(5). 414–421. 36 indexed citations

10.

Culbertson, Casey, Richard De La Garza, Matthew R. Costello, & Thomas F. Newton. (2009). Unrestricted access to methamphetamine or cocaine in the past is associated with increased current use. The International Journal of Neuropsychopharmacology. 12(5). 677–677. 2 indexed citations

11.

Garza, Richard De La, Todd Zorick, Edythe D. London, & Thomas F. Newton. (2009). Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug and Alcohol Dependence. 106(2-3). 173–180. 51 indexed citations

12.

Newton, Thomas F., Malcolm S. Reid, Richard De La Garza, et al.. (2008). Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. The International Journal of Neuropsychopharmacology. 11(8). 1037–1037. 47 indexed citations

13.

Garza, Richard De La, et al.. (2008). Predictors of Cardiovascular Response to Methamphetamine Administration in Methamphetamine‐Dependent Individuals. American Journal on Addictions. 17(2). 103–110. 10 indexed citations

14.

Mahoney, James J., Ari D. Kalechstein, Richard De La Garza, & Thomas F. Newton. (2007). A qualitative and quantitative review of cocaine-induced craving: The phenomenon of priming. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(3). 593–599. 25 indexed citations

15.

Garza, Richard De La, James J. Mahoney, Casey Culbertson, Steven Shoptaw, & Thomas F. Newton. (2007). The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. Pharmacology Biochemistry and Behavior. 89(2). 200–208. 38 indexed citations

16.

Levine, Andrew J., Charles H. Hinkin, Sarah Marion, et al.. (2006). Adherence to antiretroviral medications in HIV: Differences in data collected via self-report and electronic monitoring.. Health Psychology. 25(3). 329–335. 47 indexed citations

17.

Newton, Thomas F., et al.. (2005). Apathy predicts hedonic but not craving response to cocaine. Pharmacology Biochemistry and Behavior. 82(1). 236–240. 5 indexed citations

18.

Newton, Thomas F., John D. Roache, Richard De La Garza, et al.. (2005). Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology. 182(3). 426–435. 49 indexed citations

19.

Newton, Thomas F., Ian A. Cook, Ari D. Kalechstein, et al.. (2003). Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clinical Neurophysiology. 114(3). 410–415. 67 indexed citations

20.

Uslaner, Jason M., et al.. (1999). Association of Depressive Symptoms During Abstinence With the Subjective High Produced by Cocaine. American Journal of Psychiatry. 156(9). 1444–1446. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact